CRISPR Therapeutics AG
SEC Filing List
CRSP CIK: 0001674416
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 05/15/2026 | ||||
| SCHEDULE 13G | 05/14/2026 | ||||
| 8-K | Current report filing | Crispr Therapeutics Ag | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/04/2026 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Crispr Therapeutics Ag | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/04/2026 | |
| SCHEDULE 13G/A | Toppan Merrill/FA | 04/30/2026 | |||
| DEF 14A | Definitive proxy statements | Crispr Therapeutics Ag | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/21/2026 | |
| ARS | Annual report to security holders | Crispr Therapeutics Ag | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/21/2026 | |
| DEFA14A | Definitive additional proxy soliciting m... | Crispr Therapeutics Ag | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/21/2026 | |
| PRE 14A | Preliminary proxy statement not related ... | Crispr Therapeutics Ag | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 04/02/2026 | |
| 4 | Statement of changes in beneficial owner... | Prasad Raju | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 03/24/2026 | |
| No record found. | |||||
| Load More | |||||
